| 今开：0.0 | 昨收：1.07 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：6.5082187E7 |
智通财经APP获悉，据媒体消息，专攻免疫疗法的Surface Oncology(SURF.US)公司收到了葛兰素史克(GSK.US)的收购意向。 报道称，除葛兰素史克之外，Surface Oncology还在寻找其它任何可能的收购者。 此前，百时美施贵宝(BMY.US)在同意收... 网页链接
$Surface Oncology(SURF)$ 15-12G Securities registration termination [Section 12(g)] Accession Number: 0001193125-23-236303 Act: 34 Size: 12 KB 网页链接
$Surface Oncology(SURF)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002629 Act: 33 Size: 1 KB 网页链接
$Surface Oncology(SURF)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-002628 Act: 33 Size: 1 KB 网页链接
$Surface Oncology(SURF)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-23-231522 Act: 33 Size: 21 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231530 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231534 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231535 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231539 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231542 Act: 33 Size: 23 KB 网页链接
$Surface Oncology(SURF)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-23-231544 Act: 33 Size: 23 KB 网页链接